Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Domenico Coppola

Matched on ORCID iD 0000-0001-9090-1205; OpenAlex author ID A5076324164. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 3 papers · 2016: none · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 2 papers

Papers 14

  1. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer. Co-author DOI 10.1016/j.tranon.2019.11.009↗
  2. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2019.11.279↗
  3. Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer. Co-author DOI 10.1007/s10637-018-0676-8↗
  4. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs. Co-author DOI 10.1186/s12935-019-0876-0↗
  5. Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/pai.0000000000000368↗
  6. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis. Co-author DOI 10.18632/oncotarget.15767↗
  7. Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer. Co-author DOI 10.1016/j.radonc.2015.07.018↗
  8. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-15-0104↗
  9. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling. Co-author DOI 10.18632/oncotarget.5933↗
  10. Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. Co-author DOI 10.1371/journal.pone.0052526↗
  11. Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. First author DOI 10.1016/j.ajpath.2011.12.028↗
  12. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. First author DOI 10.1097/mpa.0b013e31823f429f↗
  13. Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318205eb03↗
  14. IκB Kinase ε expression in pancreatic ductal adenocarcinoma. Last author DOI 10.1309/ajcp2jjgyniuas2v↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mokenge Peter Malafa · 11 shared papers, 2011–2020 · strength 0.69
  2. Kazim M. Husain · 5 shared papers, 2013–2020 · strength 0.38
  3. Surinder K. Batra · 2 shared papers, 2019–2020 · strength 0.22
  4. Saı̈d M. Sebti · 3 shared papers, 2013–2019 · strength 0.21
  5. Barbara Ann Centeno · 3 shared papers, 2012–2017 · strength 0.20
  6. Amit Mahipal · 2 shared papers, 2015–2019 · strength 0.14
  7. Sridevi Challa · 1 shared paper, 2020 · strength 0.13
  8. Richard Kim · 1 shared paper, 2020 · strength 0.13
  9. Rony A. Francois · 2 shared papers, 2013–2019 · strength 0.13
  10. Heloisa Prado Soares · 1 shared paper, 2019 · strength 0.10
  11. Richard D. Kim · 1 shared paper, 2019 · strength 0.10
  12. Anuhya Kommalapati · 1 shared paper, 2019 · strength 0.10
  13. Kun Jiang · 1 shared paper, 2017 · strength 0.08
  14. Elaine S Tan · 1 shared paper, 2017 · strength 0.08
  15. Jose Gilberto Trevino · 1 shared paper, 2017 · strength 0.08
  16. Weijing Sun · 1 shared paper, 2020 · strength 0.08
  17. Prasad R. Dandawate · 1 shared paper, 2020 · strength 0.08
  18. Chandrayee Ghosh · 1 shared paper, 2020 · strength 0.08
  19. Dharmalingam Subramaniam · 1 shared paper, 2020 · strength 0.08
  20. Subhash Padhyé · 1 shared paper, 2020 · strength 0.08
  21. Shrikant Anant · 1 shared paper, 2020 · strength 0.08
  22. Anup Kasi · 1 shared paper, 2020 · strength 0.08
  23. Animesh Dhar · 1 shared paper, 2020 · strength 0.08
  24. James F. Helm · 2 shared papers, 2011–2012 · strength 0.07
  25. Dung‐Tsa Chen · 2 shared papers, 2012–2013 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.